Cargando…

Dose of Isoniazid in Renal Disease for Treatment of Tuberculosis

Detalles Bibliográficos
Autor principal:	Sarma, G. R. K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350780/ https://www.ncbi.nlm.nih.gov/pubmed/35936603 http://dx.doi.org/10.4103/aian.aian_729_21

Ejemplares similares

Isoniazid-Resistant Tuberculosis, Taiwan, 2000–2010
por: Lai, Chih-Cheng, et al.
Publicado: (2011)

Isoniazid and alopecia
por: Wiwanitkit, Somsri, et al.
Publicado: (2011)

A Case of Isoniazid Induced Cerebellitis in a Patient with Chronic Renal Failure
por: Shah, Vaishal Sanjaybhai, et al.
Publicado: (2021)

Minor Contribution of inhA-15 Mutations to the Rapid Detection of Isoniazid Resistance in Mycobacterium Tuberculosis Isolates
por: Abkar, Roya, et al.
Publicado: (2016)

Failure of Isoniazid Chemoprophylaxis during Infliximab Therapy
por: Fernández-Guerrero, Manuel L., et al.
Publicado: (2007)

Pharmacokinetics of Isoniazid-induced Rhabdomyolysis in a Girl
por: Kurane, Koyuru, et al.
Publicado: (2018)

Pure Red Blood Cell Aplasia and Isoniazid Use
por: Loulergue, Pierre, et al.
Publicado: (2007)

Renal tuberculosis tends to be low symptoms: how to improve the diagnosis and treatment of renal tuberculosis
por: Wang, Jing, et al.
Publicado: (2016)

Half-and-half nail in a case of isoniazid-induced pellagra
por: Ma, Yiping, et al.
Publicado: (2014)

Optimization of dosing regimens of isoniazid and rifampicin in children with tuberculosis in India
por: Aruldhas, Blessed Winston, et al.
Publicado: (2019)

Treatment of isoniazid-resistant pulmonary tuberculosis
por: Kim, Yee Hyung, et al.
Publicado: (2008)

Treatment of Isoniazid-Resistant Pulmonary Tuberculosis
por: Jhun, Byung Woo, et al.
Publicado: (2020)

Isoniazid related gynecomastia: Description of a case and systematic review of literature
por: Khan, Ajmal, et al.
Publicado: (2012)

Cost-effectiveness of a Pharmacogenomic Test for Stratified Isoniazid Dosing in Treatment of Active Tuberculosis
por: Rens, Neil E, et al.
Publicado: (2020)

Tuberculosis in renal transplant recipient
por: Kalita, P., et al.
Publicado: (2010)

Electrospun Orodispersible Films of Isoniazid for Pediatric Tuberculosis Treatment
por: Chachlioutaki, Konstantina, et al.
Publicado: (2020)

Isoniazid-induced liver disorder in the treatment of tuberculosis
por: Sivannan, Srinivasan, et al.
Publicado: (2018)

Concurrent renal tuberculosis and renal cell carcinoma: A coincidental finding
por: Mani, N. S., et al.
Publicado: (2013)

Cost of Delivering 12-Dose Isoniazid and Rifapentine Versus 6 Months of Isoniazid for Tuberculosis Infection in a High-Burden Setting
por: Yuen, Courtney M, et al.
Publicado: (2020)

3D-Printed Isoniazid Tablets for the Treatment and Prevention of Tuberculosis—Personalized Dosing and Drug Release
por: Öblom, Heidi, et al.
Publicado: (2019)

Time to Culture Conversion of Bedaquiline and High-Dose Isoniazid for Drug-Resistant Tuberculosis
por: Walsh, Kathleen F, et al.
Publicado: (2022)

A Lower Dose of Efavirenz Can Be Coadministered With Rifampicin and Isoniazid in Tuberculosis Patients
por: Kaboggoza, Julian P, et al.
Publicado: (2019)

A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis
por: van Beek, Stijn W., et al.
Publicado: (2021)

Impact of Isoniazid Resistance-Conferring Mutations on the Clinical Presentation of Isoniazid Monoresistant Tuberculosis
por: Dantes, Raymund, et al.
Publicado: (2012)

Hemophagocytic Syndrome with Bone Marrow Tuberculosis in Renal Transplant Recipient
por: Das, Sukanto K., et al.
Publicado: (2022)

Disseminated Tuberculosis Involving Allograft in a Renal Transplant Recipient
por: Sutariya, Harsh C., et al.
Publicado: (2016)

Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia
por: Getahun, Muluwork, et al.
Publicado: (2022)

Treatment outcomes for isoniazid-monoresistant tuberculosis in Peru, 2012-2014
por: Cornejo Garcia, Jose Gabriel, et al.
Publicado: (2018)

Clarity with INHindsight: High-Dose Isoniazid for Drug-Resistant Tuberculosis with inhA Mutations
por: Wasserman, Sean, et al.
Publicado: (2020)

Correction to: A Model-Informed Method for the Purpose of Precision Dosing of Isoniazid in Pulmonary Tuberculosis
por: van Beek, Stijn W., et al.
Publicado: (2021)

The Impact of a Knowledge Discovery-Based Psychoanalytic Intervention in the Treatment of Tuberculosis in University Students with Different Doses of Isoniazid
por: Xia, Zhihui, et al.
Publicado: (2022)

Post-tuberculosis lung diseases: Beyond treatment outcome
por: Dhamgaye, Tilak M.
Publicado: (2022)

Isoniazid Preventive Therapy and Risk for Resistant Tuberculosis
por: Balcells, Maria Elvira, et al.
Publicado: (2006)

Isoniazid for preventing tuberculosis in HIV‐infected children
por: Zunza, Moleen, et al.
Publicado: (2017)

Optimization of SABRE for polarization of the tuberculosis drugs pyrazinamide and isoniazid
por: Zeng, Haifeng, et al.
Publicado: (2013)

Risk-benefit analysis of isoniazid monotherapy to prevent tuberculosis in patients with rheumatic diseases exposed to prolonged, high-dose glucocorticoids
por: Park, Jun Won, et al.
Publicado: (2020)

Intrapatient variability in plasma rifampicin & isoniazid in tuberculosis patients
por: Kumar, A. K. Hemanth, et al.
Publicado: (2018)

Retraction: Isoniazid and Rifapentine Treatment Eradicates Persistent Mycobacterium tuberculosis in Macaques
Publicado: (2021)

Retracted: The Impact of a Knowledge Discovery-Based Psychoanalytic Intervention in the Treatment of Tuberculosis in University Students with Different Doses of Isoniazid
por: Healthcare Engineering, Journal of
Publicado: (2023)

Low dose spinal with epidural volume extension for renal transplantation in a patient with uremic cardiomyopathy
por: Srivastava, Vinit K, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mgeouekntm6rk7hi2s0a46o9ah